How Trump’s latest pharma deals may undermine efforts to rein in drug costs In agreeing to lower prices in Medicaid, drugmakers are exempt from lowering prices in Medicare

https://www.statnews.com/2026/09/02/trump-most-favored-nation-drug-pricing-industry-analysts-skeptical/ By John WilkersonSept. 2, 2026 Washington Correspondent